While patients who undergo percutaneous closure of ventricular septal defect (VSD) have a high rate of in-hospital mortality, long-term outcomes are generally favorable in those who survive to ...

Percutaneous closure of symptomatic ventricular septal defects in children can be achieved with off-label use of an occluder device. A research letter published online November 7, 2012, ahead of print ...

Percutaneous closure can be described as a less-invasive surgical procedure used to treat patients with atrial septal defect (ASD) or patent foramen ovale (PFO). Since the utilization of percutaneous ...

Isolated ventricular septal defect (VSD) is the most common congenital heart disease. [9] Some of them evolve in spontaneous closure or do not cause hemodynamically significant shunt and do not need ...

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical today announced Conformité Européenne (CE) Mark approval of the world’s first fully bioabsorbable percutaneous vascular closure device for large-bore ...

A 46-year-old female with no previously documented illnesses presented with 15 months of diarrhea, abdominal pain, and flushing after alcohol consumption. Abdominal CT showed multiple hepatic masses, ...

Mitral regurgitation (MR) is basically a consequence of a direct damage of the structural component of the valve (leaflets, papillary muscles, chordae tendineae) or of inefficient leaflet coaptation.